Articles

TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia

Center for Human Genetics, KU Leuven, Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium; Leuven Cancer Institute (LKI), KU Leuven – UZ Leuven, Leuven
Center for Human Genetics, KU Leuven, Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium; Leuven Cancer Institute (LKI), KU Leuven – UZ Leuven, Leuven
Center for Human Genetics, KU Leuven, Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium; Leuven Cancer Institute (LKI), KU Leuven – UZ Leuven, Leuven
Center for Human Genetics, KU Leuven, Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium; Leuven Cancer Institute (LKI), KU Leuven – UZ Leuven, Leuven
Center for Human Genetics, KU Leuven, Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium; Leuven Cancer Institute (LKI), KU Leuven – UZ Leuven, Leuven
Center for Human Genetics, KU Leuven, Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium; Leuven Cancer Institute (LKI), KU Leuven – UZ Leuven, Leuven
Haematologica Early view Mar 31, 2022 https://doi.org/10.3324/haematol.2021.279718